Psychedelics Numinus Expands Research Capabilities with new Phoenix Clinical Research Site February 17, 2023
Psychedelics Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder January 25, 2023
Psychedelics Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research December 8, 2022
Psychedelics Alberta Becomes the First Province to Regulate Psychoactives for Therapeutic Purposes November 30, 2022
Psychedelics Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness October 28, 2022
Psychedelics Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022 October 10, 2022